Crossmark

Piperazine-derived ionizable lipids for enhanced mRNA delivery and cancer immunotherapy

Published Online: 2024-05-30

Published Print: 2024-08

Authors

Xu, Kai

Xu, Yujia

Sun, Jin

Cheng, Xinwei

Lu, Chenxi

Chen, Wenzhong

He, Bingfang

Jiang, Tianyue
License Information

Text and Data Mining valid from 2024-05-30

Version of Record valid from 2024-05-30
More Information

Article History

Received: 3 December 2023

Revised: 15 February 2024

Accepted: 19 February 2024

First Online: 30 May 2024

Document is current